SF3A3 and colorectal carcinoma: To investigate whether SF3A3 could be a drug target for CRC treatment, we carried out a drug sensitivity test on CRC cells by intervening with phenethyl isothiocyanate (PEITC), a potential chemopreventive agent that targets the protein coded by SF3A3.